Imperial College Healthcare NHS Trust, Western Eye Hospital, 153-173 Marylebone Road, London, NW1 5QH, United Kingdom.
Institute of Ophthalmology, University College London, 11-43 Bath St, London, EC1V 9EL, United Kingdom.
Eye (Lond). 2020 Nov;34(11):2082-2088. doi: 10.1038/s41433-020-0779-2. Epub 2020 Jan 29.
To ascertain visual and refractive outcomes following toric intraocular lens (IOL) implantation in the UK National Health Service (NHS) without posterior corneal astigmatism calculation, with multiple surgeons of different grades, pooled input and output pathways and autorefraction as the refractive outcome measure.
Preoperative and 1-month post-operative data were analysed retrospectively in 114 eyes (95 patients) receiving a toric IOL between 2014 and 2016 at Imperial College NHS Trust. Preoperative keratometric astigmatism was ≥2 dioptres (D).
Mean preoperative best-corrected visual acuity (BCVA) was 0.50 logMAR (±0.46), improving to a mean uncorrected VA (UCVA) of 0.35 logMAR (±0.36) postoperatively (p < 0.001) with 65% of eyes attaining a UCVA ≤ 0.30 logMAR. Excluding 33 eyes with pre-existing visual comorbidities and one targeting monovision, mean post-operative UCVA was 0.24 logMAR (±0.29) (p < 0.001), and 85% had UCVA ≤ 0.30 logMAR, 62% UCVA ≤ 0.20 logMAR. Mean refractive astigmatism improved from 3.04 D (±1.46) to 1.36 D (±1.13) (p < 0.001). In total, 52% of eyes had post-operative refractive astigmatism ≤1.00 D. The Alpins correction index was 1.05 (±0.22), indicating a tendency to overcorrect. Toric IOL misalignment was noted in two eyes, and two cases of posterior capsule rupture were converted to a non-toric IOL.
Visual outcomes of toric IOL implantation in our pooled pathway are comparable to single-surgeon case series where posterior corneal astigmatism has not been accounted for. However, with 1-month post-operative autorefraction, only 52% of eyes had ≤1 D refractive astigmatism, which is lower than previously published series, but may be standard for 1-month autorefraction outcomes.
在英国国家医疗服务体系(NHS)中,不计算后角膜散光的情况下,由不同级别医生共同操作、采用多种输入和输出途径并以自动折射为屈光结果测量方法,对接受散光人工晶状体(IOL)植入术的患者进行视觉和屈光结果评估。
回顾性分析了 2014 年至 2016 年间在帝国理工 NHS 信托基金会接受散光 IOL 治疗的 114 只眼(95 例患者)的术前和术后 1 个月的数据。术前角膜散光≥2 屈光度(D)。
平均术前最佳矫正视力(BCVA)为 0.50 logMAR(±0.46),术后平均未矫正视力(UCVA)提高至 0.35 logMAR(±0.36)(p<0.001),65%的患者获得了 UCVA≤0.30 logMAR。排除 33 只眼存在术前视力合并症和 1 只眼目标为单视,术后平均 UCVA 为 0.24 logMAR(±0.29)(p<0.001),85%的患者 UCVA≤0.30 logMAR,62%的患者 UCVA≤0.20 logMAR。平均屈光性散光从 3.04 D(±1.46)改善至 1.36 D(±1.13)(p<0.001)。总的来说,52%的眼术后屈光性散光≤1.00 D。Alpins 矫正指数为 1.05(±0.22),表明存在过度矫正的趋势。两只眼出现了散光人工晶状体的错位,两例后囊破裂病例被转换为非散光人工晶状体。
在我们的汇总途径中,散光人工晶状体植入术的视觉结果与未考虑后角膜散光的单例手术系列相似。然而,术后 1 个月的自动折射,只有 52%的眼的屈光性散光≤1 D,这低于之前发表的系列,但可能是 1 个月自动折射结果的标准。